ライフサイエンスコーパス: allostimulation

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 hibited the response of recipient T cells to allostimulation.

2 -regulates DC activation and its function in allostimulation.

3 ells in the alloreactive pool after repeated allostimulation.

4 on occurs in all Vbeta expressing T cells by allostimulation.

5 on occurred in all Vbeta expressing cells by allostimulation.

6 pattern altered dramatically after repeated allostimulation.

7 l ligand/s (CD28 and/or CD154) could restore allostimulation.

8 duce normal cytokine levels upon third-party allostimulation.

9 ine expression following in vitro or in vivo allostimulation.

10 r beta secretion, IgG production, and T-cell allostimulation.

11 However, IL-6(-/-) BMDC induced less T cell allostimulation and Ag-specific T cell activation, but o

12 xpression and subsequent alloanergization by allostimulation and concomitant blockade of CD28-mediate

13 ubset was less potent than GFP(-) pDC2s in T allostimulation and production of tumor necrosis factor

14 -3, were enhanced most by the combination of allostimulation and rATG, than either stimulus alone.

15 Tregs were phenotypically normal, anergic to allostimulation, and suppressed proliferation of allogen

16 biological activity following polyclonal or allostimulation; and 2) tumor-specific immunosuppression

17 cells, and that both ligands participate in allostimulation, autologous proliferation, as well as sp

18 <0.001) impaired the release of sCD30 during allostimulation but did not alter the levels of ADAM10 a

19 lood T lymphocytes (CBTL) respond to primary allostimulation but they do not proliferate upon rechall

20 han 97% of migratory LC in vitro and inhibit allostimulation by LC up to 95%.

21 expression, each subset displayed different allostimulation capability in mixed lymphocyte reaction

22 in precursor frequency in response to donor allostimulation compared with the untreated control grou

23 s exhibited enhanced IFN-gamma production to allostimulation compared with young naive T cells.

24 eactive T cell clones, we performed in vitro allostimulation cultures for a cohort of patients underg

25 After allostimulation, distinct proliferating Eomes(lo)CTLA4(h

26 2) We show that allostimulation has dichotomous effects on replication o

27 etectable levels during the first 48 h after allostimulation in MLCs.

28 In vivo allostimulation in the absence of IL-2 led to exaggerate

29 n vivo during anti-CD3/anti-CD28 stimulation/allostimulation in the late phase of the alloimmune resp

30 oantigen-specific anergy in donor T cells by allostimulation in the presence of costimulatory blockad

31 graft, produce both IFN-gamma and IL-4 after allostimulation in vitro, prohibit the expansion of allo

32 transfection of DC with caTLR4 RNA enhanced allostimulation of CD4(+) T cells.

33 Allostimulation of CD4+ and CD8+ T cells by BxCM-treated

34 CB with CTLA4Ig during allostimulation of CD8+ T cells reduced CTLA4 but not Eo

35 Allostimulation of human CD4(+) T cells showed that impr

36 sed an in vitro model of alloanergization by allostimulation of human donor T cells with irradiated u

37 , Tc, T-memory and CD28 receptors, following allostimulation of peripheral blood leukocytes from 20 n

38 sion pattern of miRs and mRNAs following the allostimulation of T cells and a high correlation betwee

39 In contrast, 24-hr allostimulation of T cells from naive mice resulted in I

40 minated blood, we have tested the effects of allostimulation on HIV-1 infection.

41 o induce naive Th-cell proliferation through allostimulation or anti-CD3 monoclonal antibody stimulat

42 sponse during anti-CD3/anti-CD28 stimulation/allostimulation, prevents Treg generation, inhibits Treg

43 Allostimulation results in the up-regulation of the T-ce

44 in BTLA+/+ donor cells after 1 wk of in vivo allostimulation was not observed in BTLA-/- donor CD4+ c

45 Poor T cell responses to allostimulation were corrected by the activation and exp

46 CD8(+) T cells expanded by allostimulation were identified as CD8(+), CFSE(low) cel

47 ("alloanergization") in donor bone marrow by allostimulation with costimulatory blockade before haplo

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。